Focus Stocks
Trading Idea - Boston Scientific A Doji Close
Published on Wednesday, 04 August 2010 03:06 Written by TradersHuddle Staff
New York, August 4th (TradersHuddle.com) - Shares of Boston Scientific Corporation (NYSE:BSX) closed the trading
day higher by $0.01 or 0.18% from its previous close. Boston Scientific's shares price action formed what is considered to be a
doji close, where the open and close prices are very close to each other, mainly signaling an indecision between buyers and sellers.
Boston Scientific Corporation (NYSE:BSX) develops, manufactures, and markets minimally invasive medical device, which are used in interventional cardiology, cardiac rhythm management, and peripheral interventions, mong others.
Boston Scientific's current stock range is defined by a trough, which marks calculated support at $5.52 and by a peak that marked the resistance point at $6.62. These levels are closely watched by traders managing their positions.
Traders wanting to establish a position in Boston Scientific or traders that are already holding the stock can use the doji close to their advantage, since the pattern present a short term pause in the stock's price action. This pause results in an entry point for traders depending of which way the stock resolves this short term indecision.
Doji are important candlesticks that provide information on their own and as components in a number of important patterns. Doji form when a security's open and close are virtually equal. The length of the upper and lower shadows can vary and the resulting candlestick looks like a cross, inverted cross or plus sign. Alone, doji are neutral patterns.
Any bullish or bearish bias is based on preceding price action and future confirmation. In the case of Boston Scientific, given that the stock finished the session higher, bulls should monitor their positions for confirmation that stock will continue higher by taking today's intraday high. Below a Doji illustration:

Related Articles
- Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries
- Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference
- Boston Scientific WallFlex® Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries
- Boston Scientific Announces Global Launch of Expect™ 19 Flex Endoscopic Ultrasound Aspiration Needle
- Boston Scientific Announces Results for Fourth Quarter and Full Year Ended December 31, 2011
- Earnings Preview: Boston Scientific
- Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe
- Boston Scientific Announces Favorable Ruling in Patent Infringement Case
- Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2011 Financial Results
- Research Analyst's Up/Downgrades ( ZMH, SYK, STJ, BSX, GRMN, ONNN, AAP, RSH, KBH, LEN )
Related Partner Headlines
- Boston Scientific WallFlex Enteral Stents Shown To Be Safe and Effective in Three Clinical Registries - Benzinga
- Boston Scientific Stock Hits New 52-Week Low (BSX) - TheStreet.com
- Boston Scientific Inc. (BSX): Today's Featured Health Care Winner - TheStreet.com
- Boston Scientific Stock Hits New 52-Week Low (BSX) - TheStreet.com
- Boston Scientific Inc. (BSX): Today's Featured Health Services Winner - TheStreet.com
- Boston Scientific Slumps on 25% Profit Drop - TheStreet.com
- Boston Scientific Stock Hits New 52-Week Low (BSX) - TheStreet.com
- Boston Scientific Inc. (BSX): Today's Featured Health Services Loser - TheStreet.com
- Boston Scientific Stock Hits New 52-Week Low (BSX) - TheStreet.com
- Boston Scientific Inc. (BSX): Today's Featured Health Services Loser - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Market Morning: Flat Start as Greece Talks Stall - TheStreet.com -
Wunderlich Securities Downgrades A123 SYSTEMS from Hold to Sell, Lowers PT from to {loadposition aroundstreet}.5 - Benzinga -
EarlyBirdCapital Downgrades iRobotoration from Buy to Hold - Benzinga -
Capital One to Test Fed's 'Too Big To Fail' Cred - TheStreet.com -
Morgan Stanley Upgrades CIT Group from Equal-weight to Overweight, Raises PT from to - Benzinga -
Jefferies & Company Downgrades Solutia from Buy to Hold, Lowers PT from to .5 - Benzinga -
Rolls-Royce Posts Rise In 2011 Profit, Lifts Dividend By 9% - Benzinga -
Jefferies & Company Downgrades DuPont Fabros Technology from Buy to Hold, Lowers PT from to - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
Manulife Financial Corporation declares dividends -
Manulife Financial ends 2011 with net income of $129 million, an improvement of $1.8 billion over 2010, achieves its three-year product repositioning and continues to pursue sustainable growth -
Dunkin' Brands Reports Fourth Quarter and Full Year 2011 Results -
Ur-Energy Completes Third Uranium Sales Agreement -
Qualifying State Residents Can Get Help With Heating Bills -
Lufkin Industries Reports Strong Fourth Quarter and Full Year 2011 Earnings from Continuing Operations -
Clear Channel’s Worldwide Multi-Platform Promotion of Madonna’s New Single “Give Me All Your Luvin’” Helps Propel MDNA Album to No. 1 on iTunes, Drives Record-Breaking Sales -
COPT Reports 2011 Results; Affirms 2012 Guidance










